Where Tech Meets Bio

Where Tech Meets Bio

Home
Podcast
Weekly Highlights
Deep Dives
Sponsored Features
About
Digital Pathology: Slides, AI, & Challenges
Pathology has progressed from glass slides to AI-driven digital diagnostics, promising to transform disease detection, while facing adoption and market…
 • 
Illia Terpylo
 and 
BiopharmaTrend
Weekly Tech+Bio Highlights #51: Neurosymbolic AI for Biomedical Research
$6B AI Drug Discovery Deal & FDA’s AI Lifecycle Concept for Health Care
 • 
BiopharmaTrend
 and 
Roman Kasianov
Building the Virtual Cell: AI Foundation Models and Billion-Cell Datasets
From early 2000s and a 2012 milestone to a decade-long quiet—virtual cell modeling is resurging with transformers, perturbation atlases, and…
 • 
BiopharmaTrend
 and 
Illia Terpylo
Most Popular
View all
The '4th Wave' of AI Drug Discovery is Here, According to This Report
 • Andrii Buvailo
14 Startups in AI Protein Design: Platforms, Specialists, Modular Tools
 • BiopharmaTrend and Illia Terpylo
The Rise of AI Agents in Biotech, Where Are We Now?
 • Andrii Buvailo and BiopharmaTrend
12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials
 • BiopharmaTrend
13 Foundation Models: Startups, Industry Updates and the Nobel Prize
 • BiopharmaTrend
1
11 Biopharma Trends to Watch in 2024
 • Andrii Buvailo
Weekly Tech+Bio Highlights #50: How Robust Are Pathology Foundation Models?
CRISPR-GPT, Current Gene Delivery Landscape, & Thought-Controlled iPad
 • 
BiopharmaTrend
 and 
Roman Kasianov
H1 2025 Recap: Key Signals from the Tech+Bio Frontier
A high-signal summary of some of the most important moves and trends shaping biotech and tech-enabled life sciences in the first half of 2025
 • 
Andrii Buvailo
Weekly Tech+Bio Highlights #49: Radiology AI Grows, Impact Evidence Lags
~$1.8B in new funds and rounds; Can AI Scientists Help Rare Disease Research? & Key Tension in Applying Virtual Cell Models to Drug Development
 • 
BiopharmaTrend
 and 
Roman Kasianov
Weekly Tech+Bio Highlights #48: Bi-Weekly Overview
AI Protein Design Models, Policy Changes & Industry Funding for Q2
 • 
BiopharmaTrend
 and 
Roman Kasianov
How Organoids and AI Are Replacing Animal Testing
As FDA & NIH formalize support for non-animal testing, organ-on-a-chip, organoids, and ML-based toxicity models are being integrated into preclinical…
 • 
BiopharmaTrend
 and 
Illia Terpylo
Can AI Diagnose Better Than Humans?
With Microsoft’s agentic AI orchestrator solving NEJM cases at 85% accuracy, we profile 22+ companies advancing diagnostic AI across imaging, genomics…
 • 
BiopharmaTrend
 and 
Illia Terpylo
Weekly Tech+Bio Highlights #47: Microsoft AI's Diagnostic Multi-Agent Orchestrator
Also: New Foundation Model for Zero-Shot Antibody Design & The Role of AI in Rare Disease Tech
 • 
BiopharmaTrend
 and 
Roman Kasianov
Emerging Brain-Computer Interface Industry Across Chips, AI, and Regulation
From surgically embedded chips, adaptive neuroheadsets, and AI-steered interfaces to an intensifying geopolitical contest
 • 
BiopharmaTrend
 and 
Illia Terpylo
Weekly Tech+Bio Highlights #46: New DeepMind AI Predicts How Genes Work
~$725M in Biotech Funding, UK R&D Push, & Do We Still Need Animal Testing?
 • 
BiopharmaTrend
 and 
Roman Kasianov
Where Tech Meets Bio
Where Tech Meets Bio
What does the future hold for us in the "century of biotech"?
Recommendations
View all 6
The Algorithmic Bridge
The Algorithmic Bridge
Alberto Romero
Noahpinion
Noahpinion
Noah Smith
AI Supremacy
AI Supremacy
Michael Spencer
People vs Algorithms
People vs Algorithms
Troy Young
Special Competitive Studies Project
Special Competitive Studies Project
SCSP

Where Tech Meets Bio

AboutArchiveRecommendationsSitemap
© 2025 BiopharmaTrend (BPT Analytics Ltd)
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture